The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia

• Status: Unknown status
• Trial end date: 2007-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is exploiting the new drugs for androgenetic alopecia because there are still no effective and safe topical drug for androgenetic alopecia. Roxithomycin is one of the macrolide antibiotics that has immunomodulatory effects. We firstly found that roxithromycin increases the rate of murine and human hair follicle elongation in vitro. Therefore, we apply this drug on this disease therapy.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Hamamatsu University
• Treatments: Roxithromycin

Criteria

Inclusion Criteria:

• Androgenetic alopecia

Exclusion Criteria:

• Cicatricial alopecia

• Allergy to roxitromycin

• Children (19years old or younger)

• Pregnant female